Annual report pursuant to Section 13 and 15(d)

Segment Reporting (Tables)

v3.3.1.900
Segment Reporting (Tables)
12 Months Ended
Nov. 30, 2015
Segment Reporting [Abstract]  
Summary of Net Revenue Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense, Income Tax Benefit (Expense), Other Comprehensive Income, and Assets by Segment

The following table shows, by segment: net revenue, cost of sales, operating profit, depreciation and amortization, interest expense, income tax benefit (expense), other comprehensive income, and assets for the years ended November 30, 2015 and 2014:

 

     For the years ended November 30,  
     2015      2014  

Net revenue:

     

Umbilical cord blood and cord tissue stem cell service

   $ 20,620,138       $ 20,126,546   

Prepacyte®-CB

     471,293         —     
  

 

 

    

 

 

 

Total net revenue

   $ 21,091,431       $ 20,126,546   
  

 

 

    

 

 

 

Cost of sales:

     

Umbilical cord blood and cord tissue stem cell service

   $ 5,276,125       $ 5,632,041   

Prepacyte®-CB

     354,740         —     
  

 

 

    

 

 

 

Total cost of sales

   $ 5,630,865       $ 5,632,041   
  

 

 

    

 

 

 

Operating profit:

     

Umbilical cord blood and cord tissue stem cell service

   $ 2,842,957       $ 1,981,234   

Prepacyte®-CB

     90,267         —     
  

 

 

    

 

 

 

Total operating profit

   $ 2,933,224       $ 1,981,234   
  

 

 

    

 

 

 

Depreciation and amortization:

     

Umbilical cord blood and cord tissue stem cell service

   $ 218,567       $ 377,008   

Prepacyte®-CB

     22,640         —     
  

 

 

    

 

 

 

Total depreciation and amortization

   $ 241,207       $ 377,008   
  

 

 

    

 

 

 

Interest expense:

     

Umbilical cord blood and cord tissue stem cell service

   $ 1,277,815       $ 1,151,459   

Prepacyte®-CB

     26,057         —     
  

 

 

    

 

 

 

Total interest expense

   $ 1,303,872       $ 1,151,459   
  

 

 

    

 

 

 

Income tax benefit (expense):

     

Umbilical cord blood and cord tissue stem cell service

   $ 7,166,789       $ (123,526

Prepacyte®-CB

     (9,967      —     
  

 

 

    

 

 

 

Total income tax benefit (expense)

   $ 7,156,822       $ (123,526
  

 

 

    

 

 

 

Other comprehensive income:

     

Umbilical cord blood and cord tissue stem cell service

   $ 169,932       $ —     

Prepacyte®-CB

     —           —     
  

 

 

    

 

 

 

Total other comprehensive income

   $ 169,932       $ —     
  

 

 

    

 

 

 

Assets:

     

Umbilical cord blood and cord tissue stem cell service

   $ 16,697,621       $ 10,209,586   

Prepacyte®-CB

     2,800,325         —     
  

 

 

    

 

 

 

Total assets

   $ 19,497,946       $ 10,209,586